GlassScriptPhysician profile
Anthony B Kennedy
NPI 1922790773
$1,015.66
in general payments reported to CMS, 2019-2025
11 companies · $511 in 2025
The $511 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $139 · 2024: $366 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $380.38 | 2023-2025 | |
| Genzyme Corporation | $310.80 | 2023-2025 | |
| Abbvie INC. | $71.32 | 2024-2025 | |
| Amgen INC. | $53.31 | 2024 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $41.02 | 2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $40.68 | 2024-2025 | Tezspire |
| Genentech USA, INC. | $38.05 | 2024-2025 | Xolair |
| Kyowa Kirin, INC. | $34.83 | 2024 | Crysvita |
| Sanofi-Aventis U.S. LLC | $20.44 | 2024 | |
| Baxter Healthcare | $14.82 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Corium, LLC | $10.01 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Kennedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.